1.Current Status of Prescription in Type 2 Diabetic Patients from General Hospitals in Busan.
Ji Hye SUK ; Chang Won LEE ; Sung Pyo SON ; Min Cheol KIM ; Jun Hyeob AHN ; Kwang Jae LEE ; Ja Young PARK ; Sun Hye SHIN ; Min Jeong KWON ; Sang Soo KIM ; Bo Hyun KIM ; Soon Hee LEE ; Jeong Hyun PARK ; In Joo KIM
Diabetes & Metabolism Journal 2014;38(3):230-239
BACKGROUND: Data regarding the prescription status of individuals with diabetes are limited. This study was an analysis of participants from the relationship between cardiovascular disease and brachial-ankle pulse wave velocity in patients with type 2 diabetes (REBOUND) Study, which was a prospective multicenter cohort study recruited from eight general hospitals in Busan, Korea. We performed this study to investigate the current status of prescription in Korean type 2 diabetic patients. METHODS: Type 2 diabetic patients aged 30 years or more were recruited and data were collected for demographics, medical history, medications, blood pressure, and laboratory tests. RESULTS: Three thousands and fifty-eight type 2 diabetic patients were recruited. Mean age, duration of diabetes, and HbA1c were 59 years, 7.6 years, and 7.2%, respectively. Prevalence of hypertension was 66%. Overall, 7.3% of patients were treated with diet and exercise only, 68.2% with oral hypoglycemic agents (OHAs) only, 5.3% with insulin only, and 19.2% with both insulin and OHA. The percentage of patients using antihypertensive, antidyslipidemic, antiplatelet agents was similar as about 60%. The prevalence of statins and aspirin users was 52% and 32%, respectively. CONCLUSION: In our study, two thirds of type 2 diabetic patients were treated with OHA only, and one fifth with insulin plus OHA, and 5% with insulin only. More than half of the patients were using each of antihypertensive, antidyslipidemic, or antiplatelet agents. About a half of the patients were treated with statins and one third were treated with aspirin.
Aspirin
;
Blood Pressure
;
Busan
;
Cardiovascular Diseases
;
Cohort Studies
;
Demography
;
Diabetes Mellitus, Type 2
;
Diet
;
Drug Therapy
;
Hospitals, General*
;
Humans
;
Hydroxymethylglutaryl-CoA Reductase Inhibitors
;
Hypertension
;
Hypoglycemic Agents
;
Insulin
;
Korea
;
Platelet Aggregation Inhibitors
;
Prescriptions*
;
Prevalence
;
Prospective Studies
;
Pulse Wave Analysis